

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.48568391 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.28785530 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.04437009 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.74069100 |
| 5 | glutamate secretion (GO:0014047) | 4.54318971 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 4.52108059 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.46963898 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.34630896 |
| 9 | vocalization behavior (GO:0071625) | 4.27922394 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.26286655 |
| 11 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.16884898 |
| 12 | sodium ion export (GO:0071436) | 4.13683969 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.02091357 |
| 14 | cellular potassium ion homeostasis (GO:0030007) | 4.01945872 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.99506597 |
| 16 | regulation of synapse structural plasticity (GO:0051823) | 3.89645040 |
| 17 | neurotransmitter secretion (GO:0007269) | 3.88120680 |
| 18 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86474545 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 3.84344081 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.83756857 |
| 21 | cell communication by electrical coupling (GO:0010644) | 3.83312055 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 3.68339268 |
| 23 | cerebellar granule cell differentiation (GO:0021707) | 3.63402530 |
| 24 | activation of protein kinase A activity (GO:0034199) | 3.62195979 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.62038185 |
| 26 | exploration behavior (GO:0035640) | 3.58693948 |
| 27 | proline transport (GO:0015824) | 3.51977044 |
| 28 | cardiac muscle contraction (GO:0060048) | 3.47536115 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.45289191 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.42236615 |
| 31 | gamma-aminobutyric acid transport (GO:0015812) | 3.42087166 |
| 32 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.38755723 |
| 33 | potassium ion import (GO:0010107) | 3.38114225 |
| 34 | protein localization to synapse (GO:0035418) | 3.35244664 |
| 35 | cell communication involved in cardiac conduction (GO:0086065) | 3.22320452 |
| 36 | glycine transport (GO:0015816) | 3.21708042 |
| 37 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.19518498 |
| 38 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.15477015 |
| 39 | neuromuscular process controlling posture (GO:0050884) | 3.15342932 |
| 40 | synaptic transmission, glutamatergic (GO:0035249) | 3.14970319 |
| 41 | neurotransmitter transport (GO:0006836) | 3.13272064 |
| 42 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.11776996 |
| 43 | long-term memory (GO:0007616) | 3.10986285 |
| 44 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.10198119 |
| 45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.08695273 |
| 46 | dendritic spine morphogenesis (GO:0060997) | 3.08330373 |
| 47 | neuromuscular process controlling balance (GO:0050885) | 3.07737232 |
| 48 | membrane depolarization during action potential (GO:0086010) | 3.04114238 |
| 49 | neuron cell-cell adhesion (GO:0007158) | 3.01936594 |
| 50 | L-amino acid import (GO:0043092) | 2.99819465 |
| 51 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.98467537 |
| 52 | neuron-neuron synaptic transmission (GO:0007270) | 2.98255443 |
| 53 | potassium ion homeostasis (GO:0055075) | 2.97790619 |
| 54 | cardiac myofibril assembly (GO:0055003) | 2.97788153 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.96640548 |
| 56 | glutamate receptor signaling pathway (GO:0007215) | 2.96418421 |
| 57 | regulation of ARF protein signal transduction (GO:0032012) | 2.94913509 |
| 58 | regulation of cell communication by electrical coupling (GO:0010649) | 2.93547307 |
| 59 | positive regulation of membrane potential (GO:0045838) | 2.93038258 |
| 60 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.92111167 |
| 61 | regulation of neurotransmitter levels (GO:0001505) | 2.92092303 |
| 62 | cellular sodium ion homeostasis (GO:0006883) | 2.91956349 |
| 63 | regulation of actin filament-based movement (GO:1903115) | 2.90763162 |
| 64 | amino acid import (GO:0043090) | 2.87978548 |
| 65 | regulation of synaptic plasticity (GO:0048167) | 2.87307748 |
| 66 | sarcomere organization (GO:0045214) | 2.87144989 |
| 67 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.86024593 |
| 68 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.85919127 |
| 69 | dendrite morphogenesis (GO:0048813) | 2.85882253 |
| 70 | regulation of membrane repolarization (GO:0060306) | 2.84431757 |
| 71 | membrane repolarization (GO:0086009) | 2.83749375 |
| 72 | detection of calcium ion (GO:0005513) | 2.82972331 |
| 73 | regulation of postsynaptic membrane potential (GO:0060078) | 2.82020463 |
| 74 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.80892796 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 2.79669020 |
| 76 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.78476761 |
| 77 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.78250343 |
| 78 | neuronal ion channel clustering (GO:0045161) | 2.76784223 |
| 79 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.76639489 |
| 80 | prepulse inhibition (GO:0060134) | 2.76210501 |
| 81 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.75481114 |
| 82 | cellular response to monoamine stimulus (GO:0071868) | 2.74977535 |
| 83 | cellular response to catecholamine stimulus (GO:0071870) | 2.74977535 |
| 84 | vesicle transport along microtubule (GO:0047496) | 2.74467862 |
| 85 | synaptic vesicle endocytosis (GO:0048488) | 2.73875027 |
| 86 | positive regulation of synapse maturation (GO:0090129) | 2.73122663 |
| 87 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.70246873 |
| 88 | cellular response to epinephrine stimulus (GO:0071872) | 2.70236673 |
| 89 | plasma membrane repair (GO:0001778) | 2.68685072 |
| 90 | myofibril assembly (GO:0030239) | 2.68513019 |
| 91 | striated muscle contraction (GO:0006941) | 2.68112616 |
| 92 | membrane hyperpolarization (GO:0060081) | 2.68003408 |
| 93 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.67791820 |
| 94 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.67791820 |
| 95 | muscle filament sliding (GO:0030049) | 2.67650001 |
| 96 | actin-myosin filament sliding (GO:0033275) | 2.67650001 |
| 97 | regulation of the force of heart contraction (GO:0002026) | 2.67395236 |
| 98 | positive regulation of potassium ion transport (GO:0043268) | 2.67046278 |
| 99 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.66888344 |
| 100 | membrane depolarization (GO:0051899) | 2.65167776 |
| 101 | regulation of synapse maturation (GO:0090128) | 2.64665499 |
| 102 | cardiac muscle hypertrophy (GO:0003300) | 2.64329911 |
| 103 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.63766562 |
| 104 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.63138564 |
| 105 | regulation of neurotransmitter transport (GO:0051588) | 2.62785617 |
| 106 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.62540649 |
| 107 | cerebellar Purkinje cell layer development (GO:0021680) | 2.62228881 |
| 108 | long-term synaptic potentiation (GO:0060291) | 2.61840029 |
| 109 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.61400933 |
| 110 | auditory behavior (GO:0031223) | 2.59093003 |
| 111 | transmission of nerve impulse (GO:0019226) | 2.58844273 |
| 112 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.58622755 |
| 113 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.58299489 |
| 114 | regulation of vesicle fusion (GO:0031338) | 2.58295870 |
| 115 | alanine transport (GO:0032328) | 2.58255985 |
| 116 | response to auditory stimulus (GO:0010996) | 2.58144679 |
| 117 | positive regulation of sodium ion transport (GO:0010765) | 2.57934309 |
| 118 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.57548242 |
| 119 | establishment of nucleus localization (GO:0040023) | 2.57475526 |
| 120 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.56068588 |
| 121 | cardiac conduction (GO:0061337) | 2.53634396 |
| 122 | dendritic spine organization (GO:0097061) | 2.52380866 |
| 123 | desmosome organization (GO:0002934) | 2.52241869 |
| 124 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.51762122 |
| 125 | striated muscle hypertrophy (GO:0014897) | 2.48919336 |
| 126 | adherens junction assembly (GO:0034333) | 2.45912406 |
| 127 | protein targeting to plasma membrane (GO:0072661) | 2.45047327 |
| 128 | cell-substrate adherens junction assembly (GO:0007045) | 2.44673297 |
| 129 | focal adhesion assembly (GO:0048041) | 2.44673297 |
| 130 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.42799161 |
| 131 | response to catecholamine (GO:0071869) | 2.40094399 |
| 132 | response to monoamine (GO:0071867) | 2.40094399 |
| 133 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.39177525 |
| 134 | relaxation of cardiac muscle (GO:0055119) | 2.39069144 |
| 135 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.36539116 |
| 136 | muscle hypertrophy in response to stress (GO:0003299) | 2.36539116 |
| 137 | cardiac muscle adaptation (GO:0014887) | 2.36539116 |
| 138 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.36201741 |
| 139 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.35298696 |
| 140 | central nervous system myelination (GO:0022010) | 2.35037192 |
| 141 | axon ensheathment in central nervous system (GO:0032291) | 2.35037192 |
| 142 | actin filament depolymerization (GO:0030042) | 2.30265478 |
| 143 | postsynaptic membrane organization (GO:0001941) | 2.28337071 |
| 144 | cell-substrate junction assembly (GO:0007044) | 2.28158955 |
| 145 | actomyosin structure organization (GO:0031032) | 2.28155556 |
| 146 | response to epinephrine (GO:0071871) | 2.27750662 |
| 147 | dopamine receptor signaling pathway (GO:0007212) | 2.26366746 |
| 148 | positive regulation of dendritic spine development (GO:0060999) | 2.26357974 |
| 149 | cAMP biosynthetic process (GO:0006171) | 2.25023690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.73797652 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.77008394 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.72083368 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.61141470 |
| 5 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55220195 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55220195 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.53131754 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.45351457 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.44830811 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41724051 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37033613 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.35037864 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30937674 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.29984776 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25889267 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.24822177 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.22773695 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.15728320 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.11910523 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08978069 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.06979596 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.06190157 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.02410679 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.97283052 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94913017 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.93453894 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88699459 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.74797317 |
| 29 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.61142652 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60553530 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58807476 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51440785 |
| 33 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50002829 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49997263 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49087770 |
| 36 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.46636122 |
| 37 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.46636122 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.42898090 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42467987 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.41825242 |
| 41 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.41548027 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41263143 |
| 43 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.41222611 |
| 44 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37603900 |
| 45 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.36296184 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34653688 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34614943 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.32704760 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32013428 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.31867550 |
| 51 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.28803462 |
| 52 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28674199 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26361465 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25686084 |
| 55 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24091102 |
| 56 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23712870 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22221328 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22094625 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21045424 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20812224 |
| 61 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19993231 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19948493 |
| 63 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19358955 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19043925 |
| 65 | AR_19668381_ChIP-Seq_PC3_Human | 1.19037618 |
| 66 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16118068 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15545212 |
| 68 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.15182351 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.14649612 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14524538 |
| 71 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14255854 |
| 72 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13741341 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13064820 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12890674 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12030787 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11586650 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11459592 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11102435 |
| 79 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10718473 |
| 80 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10066999 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09694731 |
| 82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09680576 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08883995 |
| 84 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08702869 |
| 85 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.08560441 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07751007 |
| 87 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07340052 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05165498 |
| 89 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04909833 |
| 90 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04701940 |
| 91 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03341578 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 1.02506866 |
| 93 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.02083472 |
| 94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01515567 |
| 95 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00945323 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00751964 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00570052 |
| 98 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.00472854 |
| 99 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00234022 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00101897 |
| 101 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00029168 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99771480 |
| 103 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99556628 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99370308 |
| 105 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.99155928 |
| 106 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98726313 |
| 107 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98646093 |
| 108 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98310722 |
| 109 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97957484 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97329120 |
| 111 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97163240 |
| 112 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96885072 |
| 113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96695706 |
| 114 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96196429 |
| 115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95838136 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95740573 |
| 117 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95304196 |
| 118 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94166410 |
| 119 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93149636 |
| 120 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92875832 |
| 121 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92750475 |
| 122 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92515343 |
| 123 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91648351 |
| 124 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91295271 |
| 125 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90880620 |
| 126 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.90298590 |
| 127 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87993168 |
| 128 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87172032 |
| 129 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87119437 |
| 130 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87061999 |
| 131 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86898682 |
| 132 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86745103 |
| 133 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86494606 |
| 134 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.85984808 |
| 135 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84878032 |
| 136 | TP53_16413492_ChIP-PET_HCT116_Human | 0.84666486 |
| 137 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84284914 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83177997 |
| 139 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.82303760 |
| 140 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82253475 |
| 141 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.82138758 |
| 142 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81915751 |
| 143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81398256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.03143941 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.62793462 |
| 3 | MP0004270_analgesia | 3.60088241 |
| 4 | MP0003880_abnormal_central_pattern | 3.42083707 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.92792517 |
| 6 | MP0002822_catalepsy | 2.84330885 |
| 7 | MP0009745_abnormal_behavioral_response | 2.80820891 |
| 8 | MP0009046_muscle_twitch | 2.80138124 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.75171077 |
| 10 | MP0002064_seizures | 2.74092961 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.40575855 |
| 12 | MP0000751_myopathy | 2.37220285 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.36125835 |
| 14 | MP0002272_abnormal_nervous_system | 2.31578480 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.29450485 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.28439758 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.26387771 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.24220872 |
| 19 | * MP0002572_abnormal_emotion/affect_behav | 2.18914724 |
| 20 | MP0001486_abnormal_startle_reflex | 2.13124629 |
| 21 | MP0004858_abnormal_nervous_system | 2.11053104 |
| 22 | MP0008569_lethality_at_weaning | 1.99912946 |
| 23 | MP0005409_darkened_coat_color | 1.99719767 |
| 24 | MP0003329_amyloid_beta_deposits | 1.99693988 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.84203218 |
| 26 | MP0002735_abnormal_chemical_nociception | 1.81901372 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.79201271 |
| 28 | MP0001970_abnormal_pain_threshold | 1.71456859 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.70885489 |
| 30 | MP0002736_abnormal_nociception_after | 1.69546185 |
| 31 | MP0002067_abnormal_sensory_capabilities | 1.67590264 |
| 32 | MP0003646_muscle_fatigue | 1.67288617 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.65271487 |
| 34 | MP0004885_abnormal_endolymph | 1.63919451 |
| 35 | MP0003279_aneurysm | 1.61135707 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.56478747 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.56296973 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.55415462 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.49708203 |
| 40 | MP0004924_abnormal_behavior | 1.49708203 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.46768280 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.43929784 |
| 43 | MP0002184_abnormal_innervation | 1.40221257 |
| 44 | MP0004036_abnormal_muscle_relaxation | 1.39368262 |
| 45 | MP0004130_abnormal_muscle_cell | 1.38800337 |
| 46 | MP0003633_abnormal_nervous_system | 1.37833886 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.36411192 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.36092984 |
| 49 | MP0000955_abnormal_spinal_cord | 1.35872873 |
| 50 | MP0003879_abnormal_hair_cell | 1.35661482 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.33881155 |
| 52 | MP0005670_abnormal_white_adipose | 1.33672632 |
| 53 | MP0005275_abnormal_skin_tensile | 1.33013528 |
| 54 | MP0000579_abnormal_nail_morphology | 1.32775642 |
| 55 | MP0003283_abnormal_digestive_organ | 1.29720621 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.29082174 |
| 57 | MP0004043_abnormal_pH_regulation | 1.28433427 |
| 58 | * MP0002066_abnormal_motor_capabilities/c | 1.26379066 |
| 59 | MP0000778_abnormal_nervous_system | 1.23633233 |
| 60 | MP0004085_abnormal_heartbeat | 1.22157613 |
| 61 | MP0002882_abnormal_neuron_morphology | 1.21690929 |
| 62 | MP0004233_abnormal_muscle_weight | 1.21416945 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.21409379 |
| 64 | * MP0001958_emphysema | 1.20351645 |
| 65 | MP0000747_muscle_weakness | 1.19393233 |
| 66 | MP0010630_abnormal_cardiac_muscle | 1.18075703 |
| 67 | MP0003137_abnormal_impulse_conducting | 1.13931554 |
| 68 | MP0000749_muscle_degeneration | 1.13226620 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.12636084 |
| 70 | MP0006276_abnormal_autonomic_nervous | 1.10858280 |
| 71 | MP0003631_nervous_system_phenotype | 1.10297593 |
| 72 | MP0004484_altered_response_of | 1.09086035 |
| 73 | MP0003690_abnormal_glial_cell | 1.08644293 |
| 74 | MP0002249_abnormal_larynx_morphology | 1.05388972 |
| 75 | MP0005620_abnormal_muscle_contractility | 1.05104402 |
| 76 | MP0001984_abnormal_olfaction | 1.04474116 |
| 77 | MP0000750_abnormal_muscle_regeneration | 1.02698994 |
| 78 | MP0001849_ear_inflammation | 1.01772461 |
| 79 | MP0002229_neurodegeneration | 1.01233537 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.99029138 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.97826289 |
| 82 | MP0005535_abnormal_body_temperature | 0.97775337 |
| 83 | MP0008260_abnormal_autophagy | 0.97418583 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.97078661 |
| 85 | MP0004087_abnormal_muscle_fiber | 0.97026346 |
| 86 | MP0005666_abnormal_adipose_tissue | 0.96997211 |
| 87 | MP0003091_abnormal_cell_migration | 0.96758822 |
| 88 | MP0005385_cardiovascular_system_phenoty | 0.96205994 |
| 89 | MP0001544_abnormal_cardiovascular_syste | 0.96205994 |
| 90 | MP0005623_abnormal_meninges_morphology | 0.95921426 |
| 91 | MP0003634_abnormal_glial_cell | 0.95349328 |
| 92 | MP0003075_altered_response_to | 0.95255904 |
| 93 | MP0010368_abnormal_lymphatic_system | 0.95110663 |
| 94 | MP0000920_abnormal_myelination | 0.94323856 |
| 95 | MP0002972_abnormal_cardiac_muscle | 0.93904158 |
| 96 | MP0005503_abnormal_tendon_morphology | 0.93023204 |
| 97 | MP0005375_adipose_tissue_phenotype | 0.92342541 |
| 98 | MP0002090_abnormal_vision | 0.90684715 |
| 99 | MP0008874_decreased_physiological_sensi | 0.90368792 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.88883128 |
| 101 | MP0000604_amyloidosis | 0.87102402 |
| 102 | MP0004142_abnormal_muscle_tone | 0.86300350 |
| 103 | MP0005165_increased_susceptibility_to | 0.86277972 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.85890980 |
| 105 | MP0005330_cardiomyopathy | 0.84920388 |
| 106 | MP0002269_muscular_atrophy | 0.84555783 |
| 107 | MP0003172_abnormal_lysosome_physiology | 0.84178872 |
| 108 | MP0002069_abnormal_eating/drinking_beha | 0.83638054 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.82293351 |
| 110 | * MP0002152_abnormal_brain_morphology | 0.82202801 |
| 111 | MP0002108_abnormal_muscle_morphology | 0.81457377 |
| 112 | MP0000733_abnormal_muscle_development | 0.81076730 |
| 113 | MP0010234_abnormal_vibrissa_follicle | 0.78840181 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 0.78456945 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.77411465 |
| 116 | MP0003045_fibrosis | 0.77093558 |
| 117 | MP0003632_abnormal_nervous_system | 0.76380813 |
| 118 | MP0002896_abnormal_bone_mineralization | 0.76091502 |
| 119 | MP0008872_abnormal_physiological_respon | 0.75939558 |
| 120 | MP0010386_abnormal_urinary_bladder | 0.75625675 |
| 121 | MP0001905_abnormal_dopamine_level | 0.75389203 |
| 122 | MP0000759_abnormal_skeletal_muscle | 0.75218506 |
| 123 | MP0000003_abnormal_adipose_tissue | 0.74593714 |
| 124 | MP0001177_atelectasis | 0.74392651 |
| 125 | MP0004510_myositis | 0.74310007 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.74263201 |
| 127 | MP0002106_abnormal_muscle_physiology | 0.72638805 |
| 128 | MP0003122_maternal_imprinting | 0.70396718 |
| 129 | MP0006138_congestive_heart_failure | 0.70012413 |
| 130 | MP0003787_abnormal_imprinting | 0.69727328 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.69402744 |
| 132 | MP0005369_muscle_phenotype | 0.66038714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.84605241 |
| 2 | Focal motor seizures (HP:0011153) | 5.44498613 |
| 3 | Focal seizures (HP:0007359) | 4.47095801 |
| 4 | Visual hallucinations (HP:0002367) | 4.27339502 |
| 5 | Action tremor (HP:0002345) | 4.05793328 |
| 6 | Obstructive sleep apnea (HP:0002870) | 3.96823202 |
| 7 | Ventricular fibrillation (HP:0001663) | 3.53026608 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 3.48374358 |
| 9 | Ankle clonus (HP:0011448) | 3.47635575 |
| 10 | Distal lower limb muscle weakness (HP:0009053) | 3.41287098 |
| 11 | Atonic seizures (HP:0010819) | 3.40782066 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.37012352 |
| 13 | Bundle branch block (HP:0011710) | 3.33664627 |
| 14 | Epileptic encephalopathy (HP:0200134) | 3.29239795 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 3.24291306 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.10862666 |
| 17 | Ventricular tachycardia (HP:0004756) | 3.07667141 |
| 18 | Exercise-induced myalgia (HP:0003738) | 3.04120677 |
| 19 | Absence seizures (HP:0002121) | 3.04115961 |
| 20 | Depression (HP:0000716) | 3.03964078 |
| 21 | Febrile seizures (HP:0002373) | 3.02657667 |
| 22 | Sudden death (HP:0001699) | 3.00005881 |
| 23 | Postural instability (HP:0002172) | 2.99680662 |
| 24 | Increased connective tissue (HP:0009025) | 2.89093781 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 2.87756404 |
| 26 | Dysdiadochokinesis (HP:0002075) | 2.87585461 |
| 27 | Pheochromocytoma (HP:0002666) | 2.84730757 |
| 28 | Right ventricular cardiomyopathy (HP:0011663) | 2.82298335 |
| 29 | Dysmetric saccades (HP:0000641) | 2.81684801 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.78891886 |
| 31 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.77491034 |
| 32 | Poor eye contact (HP:0000817) | 2.71096876 |
| 33 | Abnormal social behavior (HP:0012433) | 2.70819853 |
| 34 | Impaired social interactions (HP:0000735) | 2.70819853 |
| 35 | Anxiety (HP:0000739) | 2.70457285 |
| 36 | Dialeptic seizures (HP:0011146) | 2.69304171 |
| 37 | Distal lower limb amyotrophy (HP:0008944) | 2.68675795 |
| 38 | Dysmetria (HP:0001310) | 2.68044439 |
| 39 | Cerebral aneurysm (HP:0004944) | 2.68038403 |
| 40 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.65385700 |
| 41 | Protrusio acetabuli (HP:0003179) | 2.64279589 |
| 42 | Prolonged QT interval (HP:0001657) | 2.63812105 |
| 43 | EMG: neuropathic changes (HP:0003445) | 2.56961139 |
| 44 | Urinary urgency (HP:0000012) | 2.55135444 |
| 45 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.54892254 |
| 46 | Abnormal eating behavior (HP:0100738) | 2.54215152 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 2.53396162 |
| 48 | Torticollis (HP:0000473) | 2.52397427 |
| 49 | Syncope (HP:0001279) | 2.52323508 |
| 50 | Abnormality of the lower motor neuron (HP:0002366) | 2.51896192 |
| 51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51619758 |
| 52 | Truncal ataxia (HP:0002078) | 2.49204388 |
| 53 | Hemiplegia (HP:0002301) | 2.47494824 |
| 54 | Foot dorsiflexor weakness (HP:0009027) | 2.47449420 |
| 55 | EMG: myopathic abnormalities (HP:0003458) | 2.46656633 |
| 56 | Broad-based gait (HP:0002136) | 2.44744177 |
| 57 | Abnormality of binocular vision (HP:0011514) | 2.44666416 |
| 58 | Diplopia (HP:0000651) | 2.44666416 |
| 59 | Papilledema (HP:0001085) | 2.44469304 |
| 60 | Intention tremor (HP:0002080) | 2.41924516 |
| 61 | Abnormality of the foot musculature (HP:0001436) | 2.39436308 |
| 62 | Abnormal EKG (HP:0003115) | 2.38364546 |
| 63 | Genetic anticipation (HP:0003743) | 2.37567536 |
| 64 | Neuroendocrine neoplasm (HP:0100634) | 2.35101083 |
| 65 | Upper limb amyotrophy (HP:0009129) | 2.33870993 |
| 66 | Distal upper limb amyotrophy (HP:0007149) | 2.33870993 |
| 67 | Difficulty climbing stairs (HP:0003551) | 2.32574101 |
| 68 | Hyporeflexia of lower limbs (HP:0002600) | 2.30394890 |
| 69 | Spastic gait (HP:0002064) | 2.29756302 |
| 70 | Termporal pattern (HP:0011008) | 2.29188665 |
| 71 | Insidious onset (HP:0003587) | 2.29188665 |
| 72 | Megalencephaly (HP:0001355) | 2.26846292 |
| 73 | Focal dystonia (HP:0004373) | 2.26459527 |
| 74 | Difficulty running (HP:0009046) | 2.25063058 |
| 75 | Lipoatrophy (HP:0100578) | 2.23558971 |
| 76 | Neurofibrillary tangles (HP:0002185) | 2.22962119 |
| 77 | Myotonia (HP:0002486) | 2.21635015 |
| 78 | Rapidly progressive (HP:0003678) | 2.19405037 |
| 79 | Aortic aneurysm (HP:0004942) | 2.19267974 |
| 80 | Shallow orbits (HP:0000586) | 2.18919130 |
| 81 | Atrial fibrillation (HP:0005110) | 2.18687559 |
| 82 | Heart block (HP:0012722) | 2.18677288 |
| 83 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.16435282 |
| 84 | Lower limb muscle weakness (HP:0007340) | 2.15307264 |
| 85 | Cerebral inclusion bodies (HP:0100314) | 2.14455764 |
| 86 | Primary atrial arrhythmia (HP:0001692) | 2.13813127 |
| 87 | Ventricular arrhythmia (HP:0004308) | 2.12884359 |
| 88 | Mutism (HP:0002300) | 2.11679347 |
| 89 | Broad face (HP:0000283) | 2.11058088 |
| 90 | Calf muscle hypertrophy (HP:0008981) | 2.11023061 |
| 91 | Bradykinesia (HP:0002067) | 2.10528377 |
| 92 | Insomnia (HP:0100785) | 2.09758149 |
| 93 | Round ear (HP:0100830) | 2.09595934 |
| 94 | Resting tremor (HP:0002322) | 2.08121235 |
| 95 | Craniofacial dystonia (HP:0012179) | 2.08109558 |
| 96 | Exercise-induced muscle cramps (HP:0003710) | 2.07299954 |
| 97 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.06973994 |
| 98 | Muscle fiber inclusion bodies (HP:0100299) | 2.06872281 |
| 99 | Spinal rigidity (HP:0003306) | 2.04439639 |
| 100 | Vascular tortuosity (HP:0004948) | 2.03962897 |
| 101 | Hyperacusis (HP:0010780) | 2.01175438 |
| 102 | Abnormal atrioventricular conduction (HP:0005150) | 2.00681615 |
| 103 | Arterial tortuosity (HP:0005116) | 2.00577226 |
| 104 | Subaortic stenosis (HP:0001682) | 1.99936525 |
| 105 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.99936525 |
| 106 | Scanning speech (HP:0002168) | 1.99769660 |
| 107 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99246912 |
| 108 | Dilated cardiomyopathy (HP:0001644) | 1.98410022 |
| 109 | Neck muscle weakness (HP:0000467) | 1.98288307 |
| 110 | Abnormality of the calf musculature (HP:0001430) | 1.98283423 |
| 111 | Impaired smooth pursuit (HP:0007772) | 1.97967020 |
| 112 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.96835670 |
| 113 | Supraventricular tachycardia (HP:0004755) | 1.96199960 |
| 114 | Hyperventilation (HP:0002883) | 1.95455381 |
| 115 | Aneurysm (HP:0002617) | 1.95209540 |
| 116 | Impaired vibratory sensation (HP:0002495) | 1.93429570 |
| 117 | Status epilepticus (HP:0002133) | 1.93408566 |
| 118 | Hemiparesis (HP:0001269) | 1.92845708 |
| 119 | Amblyopia (HP:0000646) | 1.92843006 |
| 120 | Supraventricular arrhythmia (HP:0005115) | 1.92311093 |
| 121 | Lower limb amyotrophy (HP:0007210) | 1.91290609 |
| 122 | Nemaline bodies (HP:0003798) | 1.91031787 |
| 123 | Bradycardia (HP:0001662) | 1.90204541 |
| 124 | Atrioventricular block (HP:0001678) | 1.89566614 |
| 125 | Mitral regurgitation (HP:0001653) | 1.89539210 |
| 126 | Premature rupture of membranes (HP:0001788) | 1.89303962 |
| 127 | Central scotoma (HP:0000603) | 1.88258102 |
| 128 | Postural tremor (HP:0002174) | 1.87995112 |
| 129 | Rigidity (HP:0002063) | 1.87372802 |
| 130 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.86447680 |
| 131 | Neuronal loss in central nervous system (HP:0002529) | 1.86344467 |
| 132 | Sudden cardiac death (HP:0001645) | 1.86201501 |
| 133 | Annular pancreas (HP:0001734) | 1.86059206 |
| 134 | Akinesia (HP:0002304) | 1.86030207 |
| 135 | Scapular winging (HP:0003691) | 1.85532831 |
| 136 | Agitation (HP:0000713) | 1.84413445 |
| 137 | EEG with generalized epileptiform discharges (HP:0011198) | 1.84295668 |
| 138 | Hypercortisolism (HP:0001578) | 1.84264055 |
| 139 | Stereotypic behavior (HP:0000733) | 1.84037807 |
| 140 | Epileptiform EEG discharges (HP:0011182) | 1.83891273 |
| 141 | Clonus (HP:0002169) | 1.83852817 |
| 142 | Pointed chin (HP:0000307) | 1.82776127 |
| 143 | Hypsarrhythmia (HP:0002521) | 1.80308727 |
| 144 | Myopathic facies (HP:0002058) | 1.79998155 |
| 145 | Neoplasm of the heart (HP:0100544) | 1.79748052 |
| 146 | Fragile skin (HP:0001030) | 1.79711882 |
| 147 | Increased circulating renin level (HP:0000848) | 1.79404663 |
| 148 | Axonal loss (HP:0003447) | 1.79079240 |
| 149 | Muscle fiber splitting (HP:0003555) | 1.77942819 |
| 150 | Atrophic scars (HP:0001075) | 1.77425885 |
| 151 | Bronchomalacia (HP:0002780) | 1.74761244 |
| 152 | Hand muscle atrophy (HP:0009130) | 1.74420173 |
| 153 | Tetraplegia (HP:0002445) | 1.74270947 |
| 154 | Lymphangioma (HP:0100764) | 1.73906630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.54735776 |
| 2 | MAP3K9 | 3.54113073 |
| 3 | EPHA4 | 3.21412825 |
| 4 | PRKD3 | 2.59511103 |
| 5 | MAP3K4 | 2.58574137 |
| 6 | PAK6 | 2.49197665 |
| 7 | KSR2 | 2.39889940 |
| 8 | MINK1 | 2.24845735 |
| 9 | DAPK2 | 2.20750523 |
| 10 | NTRK1 | 2.15248539 |
| 11 | LMTK2 | 2.05996185 |
| 12 | MARK1 | 2.01618643 |
| 13 | CAMKK1 | 1.97423516 |
| 14 | PHKG1 | 1.90961931 |
| 15 | PHKG2 | 1.90961931 |
| 16 | SIK1 | 1.89241267 |
| 17 | MYLK | 1.83353861 |
| 18 | NTRK2 | 1.77421198 |
| 19 | MAP2K4 | 1.75323137 |
| 20 | STK38 | 1.74932521 |
| 21 | MAP2K7 | 1.61684061 |
| 22 | TRIB3 | 1.47211516 |
| 23 | MAPK12 | 1.44329738 |
| 24 | CDK5 | 1.38541842 |
| 25 | RIPK1 | 1.38196131 |
| 26 | OBSCN | 1.36012461 |
| 27 | TESK1 | 1.34803028 |
| 28 | PINK1 | 1.32407628 |
| 29 | MAP3K2 | 1.30971178 |
| 30 | KSR1 | 1.28248069 |
| 31 | TAOK1 | 1.26501317 |
| 32 | TYRO3 | 1.22280403 |
| 33 | RET | 1.20463764 |
| 34 | LATS2 | 1.20451451 |
| 35 | PAK3 | 1.20326142 |
| 36 | PRKCH | 1.18306611 |
| 37 | CAMKK2 | 1.16866463 |
| 38 | DMPK | 1.13511849 |
| 39 | ERN1 | 1.13264279 |
| 40 | SGK223 | 1.09760734 |
| 41 | SGK494 | 1.09760734 |
| 42 | WNK1 | 1.08706348 |
| 43 | EPHB1 | 1.07620551 |
| 44 | EEF2K | 1.07275563 |
| 45 | GRK5 | 1.04063887 |
| 46 | SGK3 | 1.03731414 |
| 47 | ARAF | 1.03077955 |
| 48 | PTK2 | 1.02817749 |
| 49 | NEK1 | 1.02615423 |
| 50 | RIPK4 | 1.00261520 |
| 51 | MAP3K12 | 0.98463809 |
| 52 | MAPKAPK3 | 0.98399021 |
| 53 | MAP3K6 | 0.97959625 |
| 54 | LIMK1 | 0.97891320 |
| 55 | WNK4 | 0.97126675 |
| 56 | CAMK1 | 0.95723149 |
| 57 | UHMK1 | 0.95011680 |
| 58 | MAP3K13 | 0.94706745 |
| 59 | RPS6KA2 | 0.94395502 |
| 60 | STK11 | 0.93852715 |
| 61 | MAP3K7 | 0.92588191 |
| 62 | EPHA2 | 0.91563021 |
| 63 | OXSR1 | 0.90230774 |
| 64 | PRKCG | 0.89708967 |
| 65 | DAPK1 | 0.89156169 |
| 66 | CDK19 | 0.88533471 |
| 67 | CAMK1G | 0.87046440 |
| 68 | PDPK1 | 0.86306563 |
| 69 | MUSK | 0.86097901 |
| 70 | MAP3K1 | 0.85833739 |
| 71 | SGK2 | 0.83807529 |
| 72 | MARK2 | 0.83631701 |
| 73 | MAP3K11 | 0.82712059 |
| 74 | PDGFRA | 0.82688364 |
| 75 | SIK2 | 0.81923111 |
| 76 | CAMK2A | 0.81140001 |
| 77 | PRPF4B | 0.79164131 |
| 78 | CDC42BPA | 0.79127375 |
| 79 | PDK1 | 0.78504454 |
| 80 | TNK2 | 0.76585178 |
| 81 | DAPK3 | 0.75129647 |
| 82 | NEK6 | 0.74714456 |
| 83 | TTN | 0.73775652 |
| 84 | MAPK13 | 0.71984109 |
| 85 | FER | 0.70580510 |
| 86 | ALK | 0.70527689 |
| 87 | MAP2K3 | 0.69761048 |
| 88 | PTK2B | 0.69685408 |
| 89 | CDK15 | 0.69341630 |
| 90 | PDK3 | 0.69302975 |
| 91 | PDK4 | 0.69302975 |
| 92 | CDK18 | 0.68011283 |
| 93 | CDK14 | 0.67619337 |
| 94 | CAMK2D | 0.66473078 |
| 95 | PLK2 | 0.65227453 |
| 96 | MAPK7 | 0.64536343 |
| 97 | SMG1 | 0.64533303 |
| 98 | FES | 0.64299885 |
| 99 | PKN2 | 0.64294265 |
| 100 | TNIK | 0.62718756 |
| 101 | SGK1 | 0.61238224 |
| 102 | MAPK10 | 0.59796983 |
| 103 | STK39 | 0.59183378 |
| 104 | CDK11A | 0.57574718 |
| 105 | CAMK2B | 0.57461351 |
| 106 | CAMK4 | 0.57270168 |
| 107 | MAP3K3 | 0.56872143 |
| 108 | MTOR | 0.56735965 |
| 109 | PRKD1 | 0.56065052 |
| 110 | MAP2K1 | 0.55000966 |
| 111 | INSRR | 0.54802088 |
| 112 | RAF1 | 0.54434988 |
| 113 | DDR2 | 0.54348145 |
| 114 | FGFR4 | 0.54188009 |
| 115 | CAMK2G | 0.53587600 |
| 116 | RPS6KA3 | 0.52314434 |
| 117 | PAK2 | 0.52128393 |
| 118 | PKN1 | 0.52067248 |
| 119 | ROCK1 | 0.51863848 |
| 120 | MAPK4 | 0.50003350 |
| 121 | PRKG2 | 0.49881762 |
| 122 | PRKCZ | 0.48347723 |
| 123 | PTK6 | 0.48248434 |
| 124 | PRKAA1 | 0.47519820 |
| 125 | MET | 0.46974914 |
| 126 | WNK3 | 0.46884172 |
| 127 | PNCK | 0.46585342 |
| 128 | MAP2K6 | 0.46574270 |
| 129 | ICK | 0.45670538 |
| 130 | FGFR2 | 0.45520398 |
| 131 | PRKD2 | 0.44783157 |
| 132 | DYRK1B | 0.44644846 |
| 133 | PIK3CA | 0.44432597 |
| 134 | PRKCE | 0.44212030 |
| 135 | ROCK2 | 0.43200478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.78073883 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.41364697 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.30097503 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.27863530 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.21347955 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.19899857 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.10072642 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.06474765 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 2.03625373 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.02516797 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.98802019 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 1.89620017 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.88314393 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.88311101 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84481075 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.77051466 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73113758 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.71562429 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.69805220 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.64564500 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.58257279 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52745794 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.46933016 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.45856015 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.38512629 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.36165437 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34482619 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.33097571 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32850478 |
| 30 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.29630254 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.27549899 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.25334411 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18558295 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.18251644 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18036432 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.16333018 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.12929298 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09514452 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07343113 |
| 40 | Focal adhesion_Homo sapiens_hsa04510 | 1.07284134 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06388594 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05584795 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.02334321 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98108564 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97395716 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97060399 |
| 47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97052752 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94901375 |
| 49 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93869575 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 0.93752178 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91234578 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90683664 |
| 53 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90317803 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90088061 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.89685977 |
| 56 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87492467 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85499083 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85021451 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83216849 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 0.79734994 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79609182 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.78415261 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73966540 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70128888 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.70098107 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68445573 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67744768 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67479293 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67059246 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66607623 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66046696 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65727809 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65400762 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63971327 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63639706 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62218123 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62119078 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62072931 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60913647 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60011295 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59695576 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59636875 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58268260 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57756252 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57273166 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.56828482 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55689113 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.55565691 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.54413422 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54304095 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53464659 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52510251 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52213150 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51954606 |
| 95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51451403 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48919669 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47790602 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47083062 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.46803907 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46245962 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45960388 |
| 102 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44979236 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44855473 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44482462 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43647258 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42381876 |
| 107 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41914672 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41025043 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39766381 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38846317 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38733523 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38141472 |
| 113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37674984 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.36824720 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35566527 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.35414809 |
| 117 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33417220 |

